The history of Sildenafil presents a complex picture for those considering investment. While the initial launch generated massive gains, the lapse of its patent opened the floodgates to cheaper versions, dramatically reducing sales. This creates a particular dilemma for pharmaceutical companies depending on comparable blockbuster medications, sugge
Viagra and Big Pharma: A Risky Investment ?
The history of Viagra, and its parent company copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in sales viagra , its intellectual property lapse created a flood of generic competition , significantly eroding its market share . While some pharmaceutical companies may try to capitalize on male